The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Two Brain Sites for Cannabinoid Reward
Open accessAbstract
The recent findings that Delta9tetrahydrocannabinol (Delta9THC), the active agent in marijuana and hashish, (1) is self-administered intravenously, (2) potentiates the rewarding effects of electrical brain stimulation, and (3) can establish conditioned place preferences in laboratory animals, suggest that these drugs activate biologically primitive brain reward mechanisms. Here, we identify two chemical trigger zones for stimulant and rewarding actions of Delta9THC. Microinjections of Delta9THC into the posterior ventral tegmental area (VTA) or into the shell of the nucleus accumbens (NAS) increased locomotion, and rats learned to lever-press for injections of Delta9THC into each of these regions. Substitution of vehicle for drug or treatment with a cannabinoid CB1 receptor antagonist caused response cessation. Microinjections of Delta9THC into the posterior VTA and into the posterior shell of NAS established conditioned place preferences. Injections into the core of the NAS, the anterior VTA, or dorsal to the VTA were ineffective. These findings link the sites of rewarding action of Delta9THC to brain regions where such drugs as amphetamines, cocaine, heroin, and nicotine are also thought to have their sites of rewarding action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, rats and mice learn to self-administer opiates (Bozarth and Wise, 1981; Welzl et al., 1989; David and Cazala, 1994a; 1994b; Devine and Wise, 1994), cannabinoids (Zangen et al., 2006), cocaine (David et al., 2004; Rodd et al., 2005) or ethanol (Gatto et al., 1994; Rodd-Henricks et al., 2000) into the VTA.”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Zangen et al., 2006
In the citing paper
“The VTA at least partly mediates the rewarding effects of nicotine, opiates, cannabinoids and ethanol.”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Zangen et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085
Drug-activation of brain reward pathways
Wise, R. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00063-5 · Cited by 684
Intracranial self-administration of morphine into the ventral tegmental area in rats
Bozarth, M. A., & Wise, R. A. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90148-x · Cited by 507
Conditioned place preference using opiate and stimulant drugs: A meta-analysis
Bardo, M. T., Rowlett, J. K., & Harris, M. J. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00021-r · Cited by 421
Reynolds, S. M., & Berridge, K. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07308.2002 · Cited by 403
Self-injection of amphetamine directly into the brain
Hoebel, B. G., Monaco, A. P., Hernandez, L., Aulisi, E. F., Stanley, B. G., & Lenard, L. (1983) · Psychopharmacology · doi:10.1007/bf00429012 · Cited by 367
Research works printed but not linked: 1
- (1997), Science, 27, 2048
Cited by
Sorted by citations
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory
Ikemoto, S. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.001 · Cited by 454
Svíženská, I. H., Dubový, P., & Šulcová, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.05.010 · Cited by 475
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Phasic Dopamine Release Evoked by Abused Substances Requires Cannabinoid Receptor Activation
Cheer, J. F., Wassum, K. M., Sombers, L. A., Heien, M. L. A. V., Ariansen, J. L., Aragona, B. J., Phillips, P. E. M., & Wightman, R. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-06.2007 · Cited by 374
Mahler, S. V., Smith, K. S., & Berridge, K. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301376 · Cited by 377
Panksepp, J. (2007) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2007.00045.x · Cited by 339
Quinn, H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C., Gunasekaran, N., Thompson, M. R., Dawson, B., Mallet, P. E., Kashem, M. A., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301475 · Cited by 293
Ventral tegmental area dopamine revisited: effects of acute and repeated stress
Holly, E. N., & Miczek, K. A. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4151-3 · Cited by 265
Presynaptic Modulation by Endocannabinoids
Lovinger, D. M. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_14 · Cited by 247
The endocannabinoid system in brain reward processes
Solinas, M., Goldberg, S. R., & Piomelli, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.130 · Cited by 251
The endocannabinoid system: emotion, learning and addiction
Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 233
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions
Barrot, M., Sesack, S. R., Georges, F. E., Pistis, M., Hong, S., & Jhou, T. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3370-12.2012 · Cited by 229
Inhalant abuse among adolescents: neurobiological considerations
Lubman, D. I., Yücel, M., & Lawrence, A. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.76 · Cited by 169
Mátyás, F., Urbán, G. M., Watanabe, M., Mackie, K., Zimmer, A., Freund, T. F., & Katona, I. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.028 · Cited by 187
Bidirectional cannabinoid modulation of social behavior in adolescent rats
Trezza, V., & Vanderschuren, L. J. M. J. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1025-3 · Cited by 159
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Cooper, Z. D., & Haney, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00095.x · Cited by 158
Wenzel, J. M., & Cheer, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.126 · Cited by 161
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
[18 F ] MK ‐9470 PET measurement of cannabinoid CB 1 receptor availability in chronic cannabis users
Ceccarini, J., Kuepper, R., Kemels, D., van Os, J., Henquet, C., & Laere, K. V. (2013) · Addiction Biology · doi:10.1111/adb.12116 · Cited by 149
Dopamine, behavior, and addiction
Wise, R. A., & Jordan, C. J. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00779-7 · Cited by 153
Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence
Cooper, Z. D., & Haney, M. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782752 · Cited by 127
Functional implications of glutamatergic projections to the ventral tegmental area
Geisler, S., & Wise, R. A. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.4-5.227 · Cited by 125
Self-citationRole of nicotinic acetylcholine receptors in regulating dopamine neuron activity
Faure, P., Tolu, S., Valverde, S., & Naudé, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.040 · Cited by 125
Ikemoto, S., & Bonci, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.031 · Cited by 129
Emerging drugs of abuse: current perspectives on synthetic cannabinoids
Debruyne, D., & Boisselier, R. L. (2015) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s73586 · Cited by 117
Zhao-Shea, R., Liu, L., Soll, L. G., Improgo, M. R., Meyers, E. E., McIntosh, J. M., Grady, S. R., Marks, M. J., Gardner, P. D., & Tapper, A. R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.240 · Cited by 123
The antero-posterior heterogeneity of the ventral tegmental area
Sánchez-Catalán, M. J., Kaufling, J., Georges, F. E., Veinante, P., & Barrot, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.025 · Cited by 118
Prolonged High Fat Diet Reduces Dopamine Reuptake without Altering DAT Gene Expression
Cone, J. J., Chartoff, E. H., Potter, D. N., Ebner, S. R., & Roitman, M. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058251 · Cited by 108
Huestis, M. A., Mazzoni, I. E., & Rabin, O. (2011) · Sports Medicine · doi:10.2165/11591430-000000000-00000 · Cited by 110
Neurochemical basis of cannabis addiction
Maldonado, R. J., Berrendero, F., Ozaita, A., & Robledo, P. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.035 · Cited by 113
Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity
Katsidoni, V., Kastellakis, A., & Panagis, G. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000709 · Cited by 108
Riegel, A. C., Zapata, A. G., Shippenberg, T. S., & French, E. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301273 · Cited by 105
Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 114
Inhibition of PKMζ in Nucleus Accumbens Core Abolishes Long-Term Drug Reward Memory
Li, Y.-Q., Xue, Y.-X., He, Y., Li, F., Xue, L., Xu, C., Sacktor, T. C., Shaham, Y., & Lü, L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5884-10.2011 · Cited by 104
Hendrickson, L. M., Zhao-Shea, R., Pang, X.-Y., Gardner, P. D., & Tapper, A. R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2601-10.2010 · Cited by 101
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99
Molecular Mechanism and Cannabinoid Pharmacology
Schurman, L. D., Lu, D., Kendall, D. A., Howlett, A. C., & Lichtman, A. H. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_298 · Cited by 110
Endocannabinoid system involvement in brain reward processes related to drug abuse
Solinas, M., Yaşar, S., & Goldberg, S. R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.005 · Cited by 102
Wang, X., Luo, Y.-X., He, Y.-Y., Li, F.-Q., Shi, H.-S., Xue, L.-F., Xue, Y.-X., & Lu, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1264-10.2010 · Cited by 88
Panagis, G., Mackey, B., & Vlachou, S. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00092 · Cited by 87
Keeney, B. K., Raichlen, D. A., Meek, T. H., Wijeratne, R. S., Middleton, K. M., Gerdeman, G. L., & Garland, T. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32831c3b6b · Cited by 86
Spencer, S. M., Neuhofer, D., Chioma, V. C., García‐Keller, C., Schwartz, D., Allen, N. P., Scofield, M. D., Ortiz-Ithier, T., & Kalivas, P. W. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.016 · Cited by 83
Cannabinoid abuse and addiction: Clinical and preclinical findings
Panlilio, L. V., Goldberg, S. R., & Justinová, Z. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.118 · Cited by 74
Xu, C., Wang, J., Wu, P., Xue, Y.-X., Zhu, W., Li, Q., Zhai, H., Shi, J., & Lü, L. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07281.x · Cited by 73
Dual Role of Medial A10 Dopamine Neurons in Affective Encoding
Liu, Z., Shin, R. S., & Ikemoto, S. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.4 · Cited by 73
Conditioned taste aversion learning
Davis, C. M., & Riley, A. L. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05147.x · Cited by 75
Shabat-Simon, M., Levy, D. J., Amir, A., Rehavi, M., & Zangen, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1958-08.2008 · Cited by 70
Vlachou, S., Nomikos, G. G., Stephens, D., & Panagis, G. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282186cf2 · Cited by 69
Cannabinoid–hormone interactions in the regulation of motivational processes
López, H. H. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.10.005 · Cited by 67
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?
Johnson, K. A., & Lovinger, D. M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00264 · Cited by 67
Davis, C., Levitan, R. D., Kaplan, A. S., Carter, J., Reid, C., Curtis, C., Patte, K., & Kennedy, J. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301348 · Cited by 65
Kaufling, J., Waltisperger, E., Bourdy, R., Valera, A. M., Veinante, P., Freund‐Mercier, M. J., & Barrot, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00984.x · Cited by 66
Basic neuroanatomy and neuropharmacology of cannabinoids
Breivogel, C. S., & Sim‐Selley, L. J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782760 · Cited by 71
Linsenbardt, D. N., & Boehm, S. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.007 · Cited by 66
Taslimi, Z., Haghparast, A., Hassanpour-Ezatti, M., & Safari, M.-S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.007 · Cited by 62
Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 62
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper, Z. D., & Haney, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1875-y · Cited by 58
Cadoni, C., Simola, N., Espa, E., Fenu, S., & Chiara, G. D. (2013) · Addiction Biology · doi:10.1111/adb.12085 · Cited by 57
Lodge, D., & Grace, A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000113 · Cited by 52
Ahmad, T., Lauzon, N. M., Jaeger, X. D., & Laviolette, S. R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1686-13.2013 · Cited by 53
Song practice as a rewarding form of play in songbirds
Riters, L. V., Spool, J. A., Merullo, D. P., & Hahn, A. H. (2017) · Behavioural Processes · doi:10.1016/j.beproc.2017.10.002 · Cited by 54
Deadwyler, S. A., Goonawardena, A. V., & Hampson, R. E. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2adb · Cited by 51
Animal models of cannabinoid reward
Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00775.x · Cited by 48
Sánchez-Catalán, M. J., Hipólito, L., Zornoza, T., Polache, A., & Granero, L. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1495-6 · Cited by 48
Panagis, G., Vlachou, S., & Nomikos, G. G. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801030350 · Cited by 48
Pandolfo, P., Vendruscolo, L. F., Sordi, R., & Takahashi, R. N. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1542-3 · Cited by 48
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Sloan, M. E., Grant, C. W., Gowin, J. L., Ramchandani, V. A., & Foll, B. L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0081-z · Cited by 47
Thiemann, G., Marzo, V. D., Molleman, A., & Hasenöhrl, R. U. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.010 · Cited by 44
Kodas, E., Cohen, C., Louis, C., & Griebel, G. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0813-0 · Cited by 45
Nicotinic Facilitation of Δ9-Tetrahydrocannabinol Discrimination Involves Endogenous Anandamide
Solinas, M., Scherma, M., Tanda, G., Wertheim, C. E., Fratta, W., & Goldberg, S. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116830 · Cited by 43
Feeding Induced by Cannabinoids Is Mediated Independently of the Melanocortin System
Sinnayah, P., Jobst, E. E., Rathner, J. A., Caldera-Siu, A. D., Tonelli-Lemos, L., Eusterbrock, A. J., Enriori, P. J., Pothos, E. N., Grove, K. L., & Cowley, M. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002202 · Cited by 45
The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity
Struik, D., Sanna, F., & Fattore, L. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00249 · Cited by 44
Piray, P., Keramati, M., Dezfouli, A., Lucas, C., & Mokri, A. (2010) · Neural Computation · doi:10.1162/neco_a_00009 · Cited by 40
Rawas, R. E., Thiriet, N., Nader, J., Lardeux, V., Jaber, M., & Solinas, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.025 · Cited by 40
Jin, H., Lee, K.-W., Song, M.-J., Hyeon, Y.-J., Hwang, J.-Y., Jang, C., Ahn, J., Jeon, S.-H., Kim, H. U., Kim, Y., et al. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.039 · Cited by 39
South, T., & Huang, X. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01785.x · Cited by 39
Metabolic Messengers: endocannabinoids
Busquets-García, A., Bolaños, J. P., & Marsicano, G. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00600-1 · Cited by 43
Justinová, Z., Panlilio, L. V., & Goldberg, S. R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_13 · Cited by 40
New vistas on cannabis use disorder
Melis, M., Frau, R., Kalivas, P. W., Spencer, S. M., Chioma, V. C., Zamberletti, E., Rubino, T., & Parolaro, D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.033 · Cited by 38
Tanda, G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4244-7 · Cited by 37
Rewal, M., Donahue, R., Gill, T. M., Nie, H., Ron, D., & Janak, P. H. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00333.x · Cited by 34
Alcohol: A stimulant activating brain stress responsive systems with persistent neuroadaptation
Zhou, Y., & Kreek, M. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.044 · Cited by 34
Zhang, J., Song, C., Dai, J., Li, L., Yang, X., & Chen, Z. (2022) · MedComm · doi:10.1002/mco2.148 · Cited by 32
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29
Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond
Hempel, B. J., & Xi, Z. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.006 · Cited by 29
Norris, C., Szkudlarek, H. J., Pereira, B. J. G., Rushlow, W. J., & Laviolette, S. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-46215-7 · Cited by 28
Solinas, M., Tanda, G., Wertheim, C. E., & Goldberg, S. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1789-8 · Cited by 28
Yazdi, F., Jahangirvand, M., Pirasteh, A.-H., Moradi, M., & Haghparast, A. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.012 · Cited by 27
Harlan, B. A., Becker, H. C., Woodward, J. J., & Riegel, A. C. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0106-9 · Cited by 25
Hiranita, T., Nawata, Y., Sakimura, K., & Yamamoto, T. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.012 · Cited by 26
Sun, L., Zhang, Y., Liu, J., Wang, J., Zhu, W., Zhao, L., Xue, Y.-X., Lü, L., & Shi, J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000072 · Cited by 26
Zhou, Y., Colombo, G., Niikura, K., Carai, M. A. M., Femenía, T., García‐Gutiérrez, M. S., Manzanares, J., Ho, A., Gessa, G. L., & Kreek, M. J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01867.x · Cited by 24
Wscieklica, T., Viana, M. D. B., Sueur, L. D. P. L., Pouza, K. C. P., Spadari, R. C., & Céspedes, I. C. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.11.005 · Cited by 23
Charalambous, C., Lapka, M., Havlickova, T., Syslová, K., & Šustková-Fišerová, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010210 · Cited by 22
Zhao, B., Wang, Y., Li, Y., Qiao, X., Yan, P., Zhu, Y., & Lai, J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.03.061 · Cited by 22
Metadata
- Authors
- Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R., & Wise, R. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wise, Roy A.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-05-03
- Volume
- 26
- Issue
- 18
- Pages
- 4901-4907
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6674153
- OpenAlex
- W1994818402
- Cited by
- 174
- References
- 42
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 11 · 2016: 5 · 2015: 11 · 2014: 10 · 2013: 13 · 2012: 5
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- delta-9-tetrahydrocannabinol, ventral tegmental area, nucleus accumbens shell, conditioned place preference, locomotor activity, self-administration, CB1 receptor antagonist
- MeSH terms
- Analysis of Variance, Animals, Behavior, Animal, Cannabinoids, Conditioning, Operant, Male, Motor Activity, Nucleus Accumbens, Psychotropic Drugs, Reward, Self Stimulation, Dronabinol, Time Factors, Rats, Sprague-Dawley, Ventral Tegmental Area, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review